Search

Author/Creator Siu, Lillian L

1. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗